Jennifer D. Helble
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer D. Helble has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Michael N. Starnbach
Department of Microbiology, Harvard Medical School
4 shared publications Alex Thompson
Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, United States
1 shared publicationAnanda R. Podilapu
Department of Chemistry, Indian Institute of Technology Bombay , Powai, Mumbai, 400076, India
1 shared publicationAndrew J. Olive
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115
1 shared publicationArshed Al-Obeidi
Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, United States
1 shared publication- Ben A. Croker
Department of Pediatrics, University of California San Diego, La Jolla, USA
1 shared publication
Latest Publications
- 11 January 2021
- Published by Wiley in Parasite Immunology
- Vol. 43 (5) , e12816
Interactions between Borrelia burgdorferi and its hosts across the enzootic cycle
The bacterial pathogen Borrelia burgdorferi is the causative agent of Lyme disease and is transmitted to humans through an Ixodes tick vector. B. burgdorferi is able to survive in both mammalian and tick hosts through careful modulation of its gene expression. This allows B. burgdorferi to adapt to the environmental and nutritional changes that occur when it is transmitted between the two hosts. Distinct interactions between the spirochete and its host occur at every step of the enzootic cycle and dictate the ability of the spirochete to survive until the next stage of the cycle. Studying the interface between B. burgdorferi, the Ixodes tick vector and the natural mammalian reservoirs has been made significantly more feasible through the complete genome sequences of the organisms and the advent of high throughput screening technologies. Ultimately, a thorough investigation of the interplay between the two domains (and two phyla within one domain) is necessary in order to completely understand how the pathogen is transmitted.
- 11 January 2021
- Published by Wiley in Parasite Immunology
- Vol. 43 (5) , e12816
Interactions between Borrelia burgdorferi and its hosts across the enzootic cycle
The bacterial pathogen Borrelia burgdorferi is the causative agent of Lyme disease and is transmitted to humans through an Ixodes tick vector. B. burgdorferi is able to survive in both mammalian and tick hosts through careful modulation of its gene expression. This allows B. burgdorferi to adapt to the environmental and nutritional changes that occur when it is transmitted between the two hosts. Distinct interactions between the spirochete and its host occur at every step of the enzootic cycle and dictate the ability of the spirochete to survive until the next stage of the cycle. Studying the interface between B. burgdorferi, the Ixodes tick vector and the natural mammalian reservoirs has been made significantly more feasible through the complete genome sequences of the organisms and the advent of high throughput screening technologies. Ultimately, a thorough investigation of the interplay between the two domains (and two phyla within one domain) is necessary in order to completely understand how the pathogen is transmitted.
- Open Access
- 28 April 2020
- Published by American Society for Microbiology in mBio
- Vol. 11 (2)
Gamma Interferon Is Required forChlamydiaClearance but Is Dispensable for T Cell Homing to the Genital Tract
Chlamydia trachomatisis an important mucosal pathogen that is the leading cause of sexually transmitted bacterial infections in the United States. Despite this, there is no vaccine currently available. In order to develop such a vaccine, it is necessary to understand the components of the immune response that can lead to protection against this pathogen. It is well known that antigen-specific CD4+T cells are critical forChlamydiaclearance, but the contexts in which they are protective or not protective are unknown. Here, we aimed to characterize the importance of gamma interferon production and sensing by T cells and the effects on the immune response toC. trachomatis. Our work here helps to define the contexts in which antigen-specific T cells can be protective, which is critical to our ability to design an effective and protective vaccine againstC. trachomatis.
- 28 April 2020
- Published by American Society for Microbiology in mBio
- Vol. 11 (2)
Open AccessGamma Interferon Is Required forChlamydiaClearance but Is Dispensable for T Cell Homing to the Genital Tract
Chlamydia trachomatisis an important mucosal pathogen that is the leading cause of sexually transmitted bacterial infections in the United States. Despite this, there is no vaccine currently available. In order to develop such a vaccine, it is necessary to understand the components of the immune response that can lead to protection against this pathogen. It is well known that antigen-specific CD4+T cells are critical forChlamydiaclearance, but the contexts in which they are protective or not protective are unknown. Here, we aimed to characterize the importance of gamma interferon production and sensing by T cells and the effects on the immune response toC. trachomatis. Our work here helps to define the contexts in which antigen-specific T cells can be protective, which is critical to our ability to design an effective and protective vaccine againstC. trachomatis.
- 1 September 2019
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 87 (9)
Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection
Chlamydia trachomatis is the most commonly reported bacterial sexually transmitted infection in the United States. Modeling infection in animals can be challenging, as mice naturally clear C. trachomatis when it is deposited in the lower genital tract. However, C. trachomatis can productively infect mice when the lower genital tract is bypassed and bacteria are deposited directly into the upper genital tract via transcervical inoculation. Interestingly, the mouse-adapted Chlamydia species C. muridarum can infect mice both by transcervical inoculation and by natural ascension if introduced into the vaginal vault. In this study, we investigated whether the route of infection plays a role in the downstream immune responses to C. muridarum infection. We found that transcervical infection with C. muridarum results in higher bacterial burdens in the upper genital tract at earlier time points, correlating with levels of innate immune cells. When bacterial burdens were equivalent in intravaginally and transcervically infected mice at later time points, we observed substantially higher levels of adaptive immune cells in transcervically infected mice. Our data suggest that different routes of infection with the same organism can elicit different immune responses in the same tissue.
- 1 September 2019
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 87 (9)
Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection
Chlamydia trachomatis is the most commonly reported bacterial sexually transmitted infection in the United States. Modeling infection in animals can be challenging, as mice naturally clear C. trachomatis when it is deposited in the lower genital tract. However, C. trachomatis can productively infect mice when the lower genital tract is bypassed and bacteria are deposited directly into the upper genital tract via transcervical inoculation. Interestingly, the mouse-adapted Chlamydia species C. muridarum can infect mice both by transcervical inoculation and by natural ascension if introduced into the vaginal vault. In this study, we investigated whether the route of infection plays a role in the downstream immune responses to C. muridarum infection. We found that transcervical infection with C. muridarum results in higher bacterial burdens in the upper genital tract at earlier time points, correlating with levels of innate immune cells. When bacterial burdens were equivalent in intravaginally and transcervically infected mice at later time points, we observed substantially higher levels of adaptive immune cells in transcervically infected mice. Our data suggest that different routes of infection with the same organism can elicit different immune responses in the same tissue.
- 1 September 2019
- Published by Elsevier in Cancer Genetics
- Vol. 237, 69-77
Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics
- 1 September 2019
- Published by Elsevier in Cancer Genetics
- Vol. 237, 69-77
Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics
- 1 July 2019
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 87 (7)
A Chlamydia trachomatis Strain Expressing Ovalbumin Stimulates an Antigen-Specific CD4+T Cell Response in Mice
Antigen-specific CD4+T cells againstChlamydiaare crucial for driving bacterial clearance and mediating protection against reinfection. Although theChlamydia trachomatisprotein Cta1 has been identified to be a dominant murine CD4+T cell antigen, its level of expression during the bacterial developmental cycle and precise localization within the host cell are unknown.
- 1 July 2019
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 87 (7)
A Chlamydia trachomatis Strain Expressing Ovalbumin Stimulates an Antigen-Specific CD4+T Cell Response in Mice
Antigen-specific CD4+T cells againstChlamydiaare crucial for driving bacterial clearance and mediating protection against reinfection. Although theChlamydia trachomatisprotein Cta1 has been identified to be a dominant murine CD4+T cell antigen, its level of expression during the bacterial developmental cycle and precise localization within the host cell are unknown.
- Open Access
A FACS-Based Genome-wide CRISPR Screen Reveals a Requirement for COPI in Chlamydia trachomatis Invasion
- 9 February 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (9) , 2216-2221
Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations
Significance: Immunopathology after Chlamydia trachomatis infection is the major cause of human suffering associated with this pathogen, yet the immune responses that drive pathology are not well defined. We demonstrate that a mucosal influx of neutrophils and CXCR3-driven CD4 + and CD8 + T cells is required for C. trachomatis pathology and does not contribute to bacterial clearance. Our study decouples immune-mediated pathology from immune-mediated protection for C. trachomatis , which will have important translational implications for the development of vaccines and CXCR3-mediated treatments.
- 9 February 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (9) , 2216-2221
Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations
Significance: Immunopathology after Chlamydia trachomatis infection is the major cause of human suffering associated with this pathogen, yet the immune responses that drive pathology are not well defined. We demonstrate that a mucosal influx of neutrophils and CXCR3-driven CD4 + and CD8 + T cells is required for C. trachomatis pathology and does not contribute to bacterial clearance. Our study decouples immune-mediated pathology from immune-mediated protection for C. trachomatis , which will have important translational implications for the development of vaccines and CXCR3-mediated treatments.
- 21 October 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (12) , 3365-3373
Development of Rare Bacterial Monosaccharide Analogs for Metabolic Glycan Labeling in Pathogenic Bacteria
Bacterial glycans contain rare, exclusively bacterial monosaccharides that are frequently linked to pathogenesis and essentially absent from human cells. Therefore, bacterial glycans are intriguing molecular targets. However, systematic discovery of bacterial glycoproteins is hampered by the presence of rare deoxy amino sugars, which are refractory to traditional glycan-binding reagents. Thus, the development of chemical tools that label bacterial glycans is a crucial step toward discovering and targeting these biomolecules. Here, we explore the extent to which metabolic glycan labeling facilitates the studying and targeting of glycoproteins in a range of pathogenic and symbiotic bacterial strains. We began with an azide-containing analog of the naturally abundant monosaccharide N-acetylglucosamine and discovered that it is not broadly incorporated into bacterial glycans, thus revealing a need for additional azidosugar substrates to broaden the utility of metabolic glycan labeling in bacteria. Therefore, we designed and synthesized analogs of the rare deoxy amino d-sugars N-acetylfucosamine, bacillosamine, and 2,4-diacetamido-2,4,6-trideoxygalactose and established that these analogs are differentially incorporated into glycan-containing structures in a range of pathogenic and symbiotic bacterial species. Further application of these analogs will refine our knowledge of the glycan repertoire in diverse bacteria and may find utility in treating a variety of infectious diseases with selectivity.
- 21 October 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (12) , 3365-3373
Development of Rare Bacterial Monosaccharide Analogs for Metabolic Glycan Labeling in Pathogenic Bacteria
Bacterial glycans contain rare, exclusively bacterial monosaccharides that are frequently linked to pathogenesis and essentially absent from human cells. Therefore, bacterial glycans are intriguing molecular targets. However, systematic discovery of bacterial glycoproteins is hampered by the presence of rare deoxy amino sugars, which are refractory to traditional glycan-binding reagents. Thus, the development of chemical tools that label bacterial glycans is a crucial step toward discovering and targeting these biomolecules. Here, we explore the extent to which metabolic glycan labeling facilitates the studying and targeting of glycoproteins in a range of pathogenic and symbiotic bacterial strains. We began with an azide-containing analog of the naturally abundant monosaccharide N-acetylglucosamine and discovered that it is not broadly incorporated into bacterial glycans, thus revealing a need for additional azidosugar substrates to broaden the utility of metabolic glycan labeling in bacteria. Therefore, we designed and synthesized analogs of the rare deoxy amino d-sugars N-acetylfucosamine, bacillosamine, and 2,4-diacetamido-2,4,6-trideoxygalactose and established that these analogs are differentially incorporated into glycan-containing structures in a range of pathogenic and symbiotic bacterial species. Further application of these analogs will refine our knowledge of the glycan repertoire in diverse bacteria and may find utility in treating a variety of infectious diseases with selectivity.